FindTrial
Sign In

A Prospective Real-World Observational Study of an Empirical Rescue Regimen with Keverprazan in Patients with Persistent Helicobacter pyloriInfection after Treatment Failure

A Prospective Real-World Observational Study of an Empirical Rescue Regimen with Keverprazan in Patients with Persistent Helicobacter pyloriInfection after Treatment Failure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126876
Enrollment
Unknown
Registered
2026-06-17
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Keverprazan:None

Sponsors

The First Affiliated Hospital, Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–75 years; 2. Confirmed Helicobacter pylori (H. pylori) infection by 13C or 14C urea breath test; 3. History of at least one previous failed H. pylori eradication attempt; 4. Provision of signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Use of antibiotics or acid-suppressing agents within 4 weeks prior to screening; 2. Known hypersensitivity to any component of the study medication; 3. Pregnant or lactating women; 4. Patients with severe systemic diseases; 5. Patients deemed unsuitable for enrollment by the investigator.

Design outcomes

Primary

MeasureTime frame
Treatment success rate;—

Secondary

MeasureTime frame
Incidence and severity of side effects;—

Countries

China

Contacts

Public ContactYan Zhang

The First Affiliated Hospital, Ningbo University

nblc3344@163.com+86 574 87085233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026